Lucid Diagnostics Inc. Operating Expenses
Lucid Diagnostics Inc. (LUCD) reported Operating Expenses of $12.97 million for the 3-month period ending 2025-09-30, per its 10-Q filed 2025-11-12.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2025-11-12
- Lucid Diagnostics Inc. operating expenses for the quarter ending 2025-09-30 was $12.97M, a 0.81% increase year-over-year.
- Lucid Diagnostics Inc. operating expenses for the quarter ending 2025-06-30 was $12.55M, a 3.11% increase year-over-year.
- Lucid Diagnostics Inc. operating expenses for the quarter ending 2025-03-31 was $13.31M, a 12.91% increase year-over-year.
- Lucid Diagnostics Inc. operating expenses for the quarter ending 2024-12-31 was $13.57M, a 8.64% increase year-over-year.
- Lucid Diagnostics Inc. operating expenses for fiscal 2024 was $50.40M, a 1.01% decline from fiscal 2023.
- Lucid Diagnostics Inc. operating expenses for fiscal 2023 was $50.91M, a 10.10% decline from fiscal 2022.
- Lucid Diagnostics Inc. operating expenses for fiscal 2022 was $56.63M, a 102.83% increase from fiscal 2021.
- Lucid Diagnostics Inc. operating expenses for fiscal 2021 was $27.92M, a 237.19% increase from fiscal 2020.
| Period end | Operating Expenses 3 month | Operating Expenses 3 month as first filed | Operating Expenses 6 month | Operating Expenses 6 month as first filed | Operating Expenses 9 month | Operating Expenses 9 month as first filed | Operating Expenses 12 month | Operating Expenses 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | $12.97M 10-Q · filed 2025-11-12 | $25.52M derived: sum of 2 quarters · filed 2025-11-12 | $38.83M 10-Q · filed 2025-11-12 | $52.40M derived: sum of 4 quarters · filed 2025-11-12 | ||||
| 2025-06-30 | $12.55M 10-Q · filed 2025-08-12 | $25.86M 10-Q · filed 2025-08-12 | $39.43M derived: sum of 3 quarters · filed 2025-08-12 | $52.30M derived: sum of 4 quarters · filed 2025-11-12 | ||||
| 2025-03-31 | $13.31M 10-Q · filed 2025-05-13 | $26.89M derived: sum of 2 quarters · filed 2025-05-13 | $39.75M derived: sum of 3 quarters · filed 2025-11-12 | $51.92M derived: sum of 4 quarters · filed 2025-11-12 | ||||
| 2024-12-31 | $13.57M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24 | $26.44M derived: sum of 2 quarters · filed 2025-11-12 | $38.61M derived: sum of 3 quarters · filed 2025-11-12 | $50.40M 10-K · filed 2025-03-24 | ||||
| 2024-09-30 | $12.87M 10-Q · filed 2025-11-12 | $25.03M derived: sum of 2 quarters · filed 2025-11-12 | $36.83M 10-Q · filed 2025-11-12 | $49.32M derived: sum of 4 quarters · filed 2025-11-12 | ||||
| 2024-06-30 | $12.17M 10-Q · filed 2025-08-12 | $23.96M 10-Q · filed 2025-08-12 | $36.45M derived: sum of 3 quarters · filed 2025-08-12 | $48.37M derived: sum of 4 quarters · filed 2025-08-12 | ||||
| 2024-03-31 | $11.79M 10-Q · filed 2025-05-13 | $24.29M derived: sum of 2 quarters · filed 2025-05-13 | $36.20M derived: sum of 3 quarters · filed 2025-05-13 | $47.94M derived: sum of 4 quarters · filed 2025-05-13 | ||||
| 2023-12-31 | $12.49M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24 | $24.40M derived: sum of 2 quarters · filed 2025-03-24 | $36.15M derived: sum of 3 quarters · filed 2025-03-24 | $50.91M 10-K · filed 2025-03-24 | ||||
| 2023-09-30 | $11.91M 10-Q · filed 2024-11-12 | $23.65M derived: sum of 2 quarters · filed 2024-11-12 | $38.42M 10-Q · filed 2024-11-12 | $53.50M derived: sum of 4 quarters · filed 2024-11-12 | ||||
| 2023-06-30 | $11.74M 10-Q · filed 2024-08-12 | $26.50M 10-Q · filed 2024-08-12 | $41.59M derived: sum of 3 quarters · filed 2024-08-12 | $56.05M derived: sum of 4 quarters · filed 2024-08-12 | ||||
| 2023-03-31 | $14.76M 10-Q · filed 2024-05-13 | $29.85M derived: sum of 2 quarters · filed 2024-05-13 | $44.30M derived: sum of 3 quarters · filed 2024-05-13 | $58.93M derived: sum of 4 quarters · filed 2024-05-13 | ||||
| 2022-12-31 | $15.09M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-25 | $29.54M derived: sum of 2 quarters · filed 2024-03-25 | $44.17M derived: sum of 3 quarters · filed 2024-03-25 | $56.63M 10-K · filed 2024-03-25 | $56.55M 10-K · filed 2023-03-14 | |||
| 2022-09-30 | $14.45M 10-Q · filed 2023-11-13 | $14.43M 10-Q · filed 2022-11-14 | $29.08M derived: sum of 2 quarters · filed 2023-11-13 | $41.54M 10-Q · filed 2023-11-13 | $41.51M 10-Q · filed 2022-11-14 | $53.08M derived: sum of 4 quarters · filed 2023-11-13 | ||
| 2022-06-30 | $14.63M 10-Q · filed 2023-08-14 | $14.62M 10-Q · filed 2022-08-15 | $27.09M 10-Q · filed 2023-08-14 | $26.71M 10-Q · filed 2022-08-15 | $38.63M derived: sum of 3 quarters · filed 2023-08-14 | $45.34M derived: sum of 4 quarters · filed 2023-08-14 | ||
| 2022-03-31 | $12.46M 10-Q · filed 2023-05-15 | $11.92M 10-Q · filed 2022-05-16 | $24.00M derived: sum of 2 quarters · filed 2023-05-15 | $30.71M derived: sum of 3 quarters · filed 2023-05-15 | $36.73M derived: sum of 4 quarters · filed 2023-05-15 | |||
| 2021-12-31 | $11.54M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-14 | $18.25M derived: sum of 2 quarters · filed 2023-03-14 | $24.27M derived: sum of 3 quarters · filed 2023-03-14 | $27.92M 10-K · filed 2023-03-14 | $27.33M 10-K · filed 2022-04-06 | |||
| 2021-09-30 | $6.71M 10-Q · filed 2022-11-14 | $6.57M 10-Q · filed 2021-11-23 | $12.73M derived: sum of 2 quarters · filed 2022-11-14 | $16.38M 10-Q · filed 2022-11-14 | $16.23M 10-Q · filed 2021-11-23 | $19.11M derived: sum of 4 quarters · filed 2022-11-14 | ||
| 2021-06-30 | $6.02M 10-Q · filed 2022-08-15 | $9.67M 10-Q · filed 2022-08-15 | $12.40M derived: sum of 3 quarters · filed 2022-08-15 | $14.42M derived: sum of 4 quarters · filed 2022-08-15 | ||||
| 2021-03-31 | $3.65M 10-Q · filed 2022-05-16 | $6.38M derived: sum of 2 quarters · filed 2022-05-16 | $8.41M derived: sum of 3 quarters · filed 2022-05-16 | |||||
| 2020-12-31 | $2.73M derived: 10-K 12 month − 10-Q 9 month · filed 2022-04-06 | $4.75M derived: sum of 2 quarters · filed 2022-04-06 | $8.28M 10-K · filed 2022-04-06 | |||||
| 2020-09-30 | $2.02M 10-Q · filed 2021-11-23 | $5.55M 10-Q · filed 2021-11-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| Apyx Medical Corp (APYX) | United States | $0.120B | -21.85 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |